624 related articles for article (PubMed ID: 28155174)
41. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study.
Hoang TD; Olsen CH; Mai VQ; Clyde PW; Shakir MK
J Clin Endocrinol Metab; 2013 May; 98(5):1982-90. PubMed ID: 23539727
[TBL] [Abstract][Full Text] [Related]
42. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
43. Follow-up of congenital heart disease patients with subclinical hypothyroidism.
Martínez-Quintana E; Rodríguez-González F
Cardiol Young; 2015 Aug; 25(6):1111-8. PubMed ID: 25247450
[TBL] [Abstract][Full Text] [Related]
44. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
45. Thyroid Stimulating Hormone Stability in Patients Prescribed Synthetic or Desiccated Thyroid Products: A Retrospective Study.
Kuye R; Riggs C; King J; Heilmann R; Kurz D; Milchak J
Ann Fam Med; 2020 Sep; 18(5):452-454. PubMed ID: 32928762
[TBL] [Abstract][Full Text] [Related]
46. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
[TBL] [Abstract][Full Text] [Related]
47. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
Rana S; Nunlee-Bland G; Valyasevi R; Iqbal M
Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
[TBL] [Abstract][Full Text] [Related]
48. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
Ain KB; Pucino F; Shiver TM; Banks SM
Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
[TBL] [Abstract][Full Text] [Related]
49. Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism.
Figge J; Dluhy RG
Ann Intern Med; 1990 Oct; 113(7):553-5. PubMed ID: 2393210
[No Abstract] [Full Text] [Related]
50. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy?
Chopra IJ; Baber K
Metabolism; 2003 Jan; 52(1):122-8. PubMed ID: 12524672
[TBL] [Abstract][Full Text] [Related]
51. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN; Iqbal A; Minassian C; Sayers A; Draman MS; Greenwood R; Hamilton W; Okosieme O; Panicker V; Thomas SL; Dayan C
JAMA Intern Med; 2014 Jan; 174(1):32-9. PubMed ID: 24100714
[TBL] [Abstract][Full Text] [Related]
52. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.
De Whalley P
Br J Gen Pract; 1995 Feb; 45(391):93-5. PubMed ID: 7702890
[TBL] [Abstract][Full Text] [Related]
53. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound.
Rosário PW; Bessa B; Valadão MM; Purisch S
Thyroid; 2009 Jan; 19(1):9-12. PubMed ID: 19021461
[TBL] [Abstract][Full Text] [Related]
54. Use of soy protein supplement and resultant need for increased dose of levothyroxine.
Bell DS; Ovalle F
Endocr Pract; 2001; 7(3):193-4. PubMed ID: 11421567
[TBL] [Abstract][Full Text] [Related]
55. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
56. Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism.
Ravanbod M; Asadipooya K; Kalantarhormozi M; Nabipour I; Omrani GR
Am J Med; 2013 May; 126(5):420-4. PubMed ID: 23582934
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
[TBL] [Abstract][Full Text] [Related]
58. Assessment of interchangeability of two brands of levothyroxine preparations with a third-generation TSH assay.
Escalante DA; Arem N; Arem R
Am J Med; 1995 Apr; 98(4):374-8. PubMed ID: 7709950
[TBL] [Abstract][Full Text] [Related]
59. Effect of thyroid hormone replacement on methionine-stimulated homocysteine levels in patients with subclinical hypothyroidism: a randomized, double-blind, placebo-controlled study.
Meek S; Smallridge RC
Endocr Pract; 2006; 12(5):529-34. PubMed ID: 17002927
[TBL] [Abstract][Full Text] [Related]
60. Thyroid function from birth to adolescence in Prader-Willi syndrome.
Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
